Huaren Pharmaceutical Co., Ltd.
Huaren Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has established a strong presence in both domestic and international markets, focusing on innovative solutions in areas such as oncology, cardiology, and infectious diseases. With a commitment to excellence, Huaren Pharmaceutical offers a diverse portfolio of core products, including generic medications and proprietary formulations that stand out for their efficacy and safety. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. Recognised for its dedication to quality and innovation, Huaren Pharmaceutical continues to contribute to global health advancements while maintaining a strong reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Huaren Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huaren Pharmaceutical Co., Ltd.'s score of 12 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Huaren Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Huaren Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 152,103,450 kg CO2e. This figure includes about 14,288,850 kg CO2e from Scope 1 emissions and approximately 137,814,600 kg CO2e from Scope 2 emissions. The previous year, 2022, the company recorded total emissions of about 108,596,090 kg CO2e, with Scope 1 emissions at approximately 11,305,600 kg CO2e and Scope 2 emissions at around 97,290,490 kg CO2e. Despite the increase in total emissions from 2022 to 2023, there are currently no publicly disclosed reduction targets or climate pledges from Huaren Pharmaceutical. The company has not specified any initiatives under the Science Based Targets initiative (SBTi) or other reduction commitments. As a result, the industry context suggests a need for enhanced climate action and transparency in emissions reduction strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 11,305,600 | 00,000,000 |
| Scope 2 | 97,290,490 | 000,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huaren Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
